Related references
Note: Only part of the references are listed.Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer
Oscar G. F. Geessink et al.
CELLULAR ONCOLOGY (2019)
A Fast and Refined Cancer Regions Segmentation Framework in Whole-slide Breast Pathological Images
Zichao Guo et al.
SCIENTIFIC REPORTS (2019)
Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
Silvana Anna Maria Urru et al.
BMC CANCER (2018)
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study
Mark O'Loughlin et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Tumor-infiltrating lymphocyte volume is a better predictor of neoadjuvant therapy response and overall survival in triple-negative invasive breast cancer
Lin Zhang et al.
HUMAN PATHOLOGY (2018)
Whole-Slide Mitosis Detection in H&E Breast Histology Using PHH3 as a Reference to Train Distilled Stain-Invariant Convolutional Networks
David Tellez et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2018)
Breast cancer histologic grading using digital microscopy: concordance and outcome association
Emad A. Rakha et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer
Nirmesh Patel et al.
NATURE COMMUNICATIONS (2018)
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
Karin Beelen et al.
BMC CANCER (2018)
Impact of Deep Learning Assistance on the Histopathologic Review of Lymph Nodes for Metastatic Breast Cancer
David F. Steiner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
Roberto A. Leon-Ferre et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
Babak Ehteshami Bejnordi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
Yunbao Pan et al.
PLOS ONE (2017)
The Spectrum of Triple-Negative Breast Disease High- and Low-Grade Lesions
Felipe C. Geyer et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Mitosis Counting in Breast Cancer: Object-Level Interobserver Agreement and Comparison to an Automatic Method
Mitko Veta et al.
PLOS ONE (2016)
BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer
Hitomi Mori et al.
PLOS ONE (2016)
A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research
Terry K. Koo et al.
JOURNAL OF CHIROPRACTIC MEDICINE (2016)
Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma
James M. Chang et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Patrick M. Bossuyt et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Patrick M. Bossuyt et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Translating the Molecular Message of Triple-Negative Breast Cancer into Targeted Therapy
Neelima Vidula et al.
CLINICAL CANCER RESEARCH (2015)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the Outcome
Emilia Montagna et al.
CLINICAL BREAST CANCER (2013)
Quantifying discrimination of Framingham risk functions with different survival C statistics
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2012)
In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up
P. Bult et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2008)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years
JPA Baak et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy
P Manders et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Share Paper
